A Boulder-based startup that developed lozenges to help people rebalance their hormones and reduce their anxiety, secured a $7.37 million Series C round this week. This funding comes five months after the startup launched its first products.
A Boulder-based startup that developed lozenges to help people rebalance their hormones and reduce their anxiety, secured a $7.37 million Series C round this week. This funding comes five months after the startup launched its first products.
